Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor

Detalhes bibliográficos
Autor(a) principal: Sá, Claudia Cristina de
Data de Publicação: 2011
Outros Autores: Kishi, Humberto Setsuo, Silva-Werneck, Ana Luiza, Moraes-Filho, Joaquim Prado Pinto de, Eisig, Jaime Natan, Barbuti, Ricardo Correa, Hashimoto, Claudio Lyioti, Navarro-Rodriguez, Tomas
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
DOI: 10.1590/S1807-59322011000400006
Texto Completo: https://www.revistas.usp.br/clinics/article/view/19584
Resumo: BACKGROUND: TREATMEN The contribution of eosinophilic esophagitis (EoE) to refractory gastroesophageal reflux disease (GERD) remains unknown. When EoE and GERD overlap, the clinical, endoscopic and histological findings are nonspecific and cannot be used to distinguish between the two disorders. Limited data are available on this topic, and the interaction between EoE and GERD is a matter of debate. AIM: We have conducted a prospective study of adult patients with refractory GERD to evaluate the overlap of reflux and EoE. METHODS: Between July 2006 and June 2008, we consecutively and prospectively enrolled 130 male and female patients aged 18 to 70 years old who experienced persistent heartburn and/or regurgitation more than twice a week over the last 30 days while undergoing at least six consecutive weeks of omeprazole treatment (at least 40 mg once a day). The patients underwent an upper digestive endoscopy with esophageal biopsy, and intraepithelial eosinophils were counted after hematoxylin/eosin staining. The diagnosis of EoE was based on the presence of 20 or more eosinophils per high-power field (eo/HPF) in esophageal biopsies. RESULTS: Among the 103 studied patients, 79 (76.7%) were females. The patients had a mean age of 45.5 years and a median age of 47 years. Endoscopy was normal in 83.5% of patients, and erosive esophagitis was found in 12.6%. Only one patient presented lesions suggestive of EoE. Histological examination revealed >;20 eo/HPF in this patient. CONCLUSION: Our results demonstrated a low prevalence of EoE among patients with refractory GERD undergoing omeprazole treatment.
id USP-19_d3bfbd4e6f015a825091368e18670c1d
oai_identifier_str oai:revistas.usp.br:article/19584
network_acronym_str USP-19
network_name_str Clinics
spelling Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor Refractory Gastroesophageal Reflux DiseaseEosinophilic EsophagitisHeartburnAcid Regurgitation BACKGROUND: TREATMEN The contribution of eosinophilic esophagitis (EoE) to refractory gastroesophageal reflux disease (GERD) remains unknown. When EoE and GERD overlap, the clinical, endoscopic and histological findings are nonspecific and cannot be used to distinguish between the two disorders. Limited data are available on this topic, and the interaction between EoE and GERD is a matter of debate. AIM: We have conducted a prospective study of adult patients with refractory GERD to evaluate the overlap of reflux and EoE. METHODS: Between July 2006 and June 2008, we consecutively and prospectively enrolled 130 male and female patients aged 18 to 70 years old who experienced persistent heartburn and/or regurgitation more than twice a week over the last 30 days while undergoing at least six consecutive weeks of omeprazole treatment (at least 40 mg once a day). The patients underwent an upper digestive endoscopy with esophageal biopsy, and intraepithelial eosinophils were counted after hematoxylin/eosin staining. The diagnosis of EoE was based on the presence of 20 or more eosinophils per high-power field (eo/HPF) in esophageal biopsies. RESULTS: Among the 103 studied patients, 79 (76.7%) were females. The patients had a mean age of 45.5 years and a median age of 47 years. Endoscopy was normal in 83.5% of patients, and erosive esophagitis was found in 12.6%. Only one patient presented lesions suggestive of EoE. Histological examination revealed >;20 eo/HPF in this patient. CONCLUSION: Our results demonstrated a low prevalence of EoE among patients with refractory GERD undergoing omeprazole treatment. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2011-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/1958410.1590/S1807-59322011000400006Clinics; Vol. 66 No. 4 (2011); 557-561 Clinics; v. 66 n. 4 (2011); 557-561 Clinics; Vol. 66 Núm. 4 (2011); 557-561 1980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/19584/21647Sá, Claudia Cristina deKishi, Humberto SetsuoSilva-Werneck, Ana LuizaMoraes-Filho, Joaquim Prado Pinto deEisig, Jaime NatanBarbuti, Ricardo CorreaHashimoto, Claudio LyiotiNavarro-Rodriguez, Tomasinfo:eu-repo/semantics/openAccess2012-05-23T16:49:58Zoai:revistas.usp.br:article/19584Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2012-05-23T16:49:58Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
title Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
spellingShingle Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
Sá, Claudia Cristina de
Refractory Gastroesophageal Reflux Disease
Eosinophilic Esophagitis
Heartburn
Acid Regurgitation
Sá, Claudia Cristina de
Refractory Gastroesophageal Reflux Disease
Eosinophilic Esophagitis
Heartburn
Acid Regurgitation
title_short Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
title_full Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
title_fullStr Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
title_full_unstemmed Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
title_sort Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
author Sá, Claudia Cristina de
author_facet Sá, Claudia Cristina de
Sá, Claudia Cristina de
Kishi, Humberto Setsuo
Silva-Werneck, Ana Luiza
Moraes-Filho, Joaquim Prado Pinto de
Eisig, Jaime Natan
Barbuti, Ricardo Correa
Hashimoto, Claudio Lyioti
Navarro-Rodriguez, Tomas
Kishi, Humberto Setsuo
Silva-Werneck, Ana Luiza
Moraes-Filho, Joaquim Prado Pinto de
Eisig, Jaime Natan
Barbuti, Ricardo Correa
Hashimoto, Claudio Lyioti
Navarro-Rodriguez, Tomas
author_role author
author2 Kishi, Humberto Setsuo
Silva-Werneck, Ana Luiza
Moraes-Filho, Joaquim Prado Pinto de
Eisig, Jaime Natan
Barbuti, Ricardo Correa
Hashimoto, Claudio Lyioti
Navarro-Rodriguez, Tomas
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Sá, Claudia Cristina de
Kishi, Humberto Setsuo
Silva-Werneck, Ana Luiza
Moraes-Filho, Joaquim Prado Pinto de
Eisig, Jaime Natan
Barbuti, Ricardo Correa
Hashimoto, Claudio Lyioti
Navarro-Rodriguez, Tomas
dc.subject.por.fl_str_mv Refractory Gastroesophageal Reflux Disease
Eosinophilic Esophagitis
Heartburn
Acid Regurgitation
topic Refractory Gastroesophageal Reflux Disease
Eosinophilic Esophagitis
Heartburn
Acid Regurgitation
description BACKGROUND: TREATMEN The contribution of eosinophilic esophagitis (EoE) to refractory gastroesophageal reflux disease (GERD) remains unknown. When EoE and GERD overlap, the clinical, endoscopic and histological findings are nonspecific and cannot be used to distinguish between the two disorders. Limited data are available on this topic, and the interaction between EoE and GERD is a matter of debate. AIM: We have conducted a prospective study of adult patients with refractory GERD to evaluate the overlap of reflux and EoE. METHODS: Between July 2006 and June 2008, we consecutively and prospectively enrolled 130 male and female patients aged 18 to 70 years old who experienced persistent heartburn and/or regurgitation more than twice a week over the last 30 days while undergoing at least six consecutive weeks of omeprazole treatment (at least 40 mg once a day). The patients underwent an upper digestive endoscopy with esophageal biopsy, and intraepithelial eosinophils were counted after hematoxylin/eosin staining. The diagnosis of EoE was based on the presence of 20 or more eosinophils per high-power field (eo/HPF) in esophageal biopsies. RESULTS: Among the 103 studied patients, 79 (76.7%) were females. The patients had a mean age of 45.5 years and a median age of 47 years. Endoscopy was normal in 83.5% of patients, and erosive esophagitis was found in 12.6%. Only one patient presented lesions suggestive of EoE. Histological examination revealed >;20 eo/HPF in this patient. CONCLUSION: Our results demonstrated a low prevalence of EoE among patients with refractory GERD undergoing omeprazole treatment.
publishDate 2011
dc.date.none.fl_str_mv 2011-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/19584
10.1590/S1807-59322011000400006
url https://www.revistas.usp.br/clinics/article/view/19584
identifier_str_mv 10.1590/S1807-59322011000400006
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/19584/21647
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 66 No. 4 (2011); 557-561
Clinics; v. 66 n. 4 (2011); 557-561
Clinics; Vol. 66 Núm. 4 (2011); 557-561
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1822178958871887872
dc.identifier.doi.none.fl_str_mv 10.1590/S1807-59322011000400006